On May 31, 2023, Altamira Therapeutics Ltd., closed the transaction.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.465 USD | +1.03% | -11.59% | -58.33% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-58.33% | 3.25M | |
+4.97% | 109B | |
+11.20% | 105B | |
-0.38% | 22.25B | |
-12.33% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.97% | 16.85B | |
+4.46% | 13.76B | |
+34.90% | 12.46B |
- Stock Market
- Equities
- CYTO Stock
- News Altamira Therapeutics Ltd.
- Altamira Therapeutics Ltd. announced that it has received CHF 2.5 million in funding from FiveT Investment Management Ltd.